# Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Subjects

> **NCT04053023** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 19 (actual)

## Conditions studied

- Cholestasis

## Interventions

- **DRUG:** GSK2330672 (linerixibat)
- **DRUG:** Obeticholic acid

## Key facts

- **NCT ID:** NCT04053023
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-27
- **Primary completion:** 2019-11-25
- **Final completion:** 2019-11-25
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2020-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04053023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04053023, "Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04053023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*